Home › Funds › LEUTHOLD GROUP, LLC › VRTX

LEUTHOLD GROUP, LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

LEUTHOLD GROUP, LLC reported holding 17,113 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$8.9M, representing 0.84% of its reported portfolio and ranking #38 among its reported holdings. LEUTHOLD GROUP, LLC has disclosed VRTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)17.11K sh
Reported value held$8.95M
Portfolio Weight0.84%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LEUTHOLD GROUP, LLC's VRTX position evolved

LEUTHOLD GROUP, LLC first disclosed a stake in VRTX in Q3 2025 at 12,843 shares (US$5.0M). The position peaked in Q3 2026 at 17,113 shares, worth US$8.9M. Across 5 filings, LEUTHOLD GROUP, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 17,113 shares valued at US$8.9M — an increase of 1,473 shares quarter over quarter.. Notable position changes include a 28% increase in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 12.84K $5.03M New
Q4 2025 16.41K $7.44M Add
Q1 2026 16.45K $7.35M Hold
Q2 2026 15.64K $7.77M Reduce
Q3 2026 17.11K $8.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has LEUTHOLD GROUP, LLC held VRTX?

LEUTHOLD GROUP, LLC has disclosed VRTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is LEUTHOLD GROUP, LLC's current position in VRTX?

As of Q3 2026, LEUTHOLD GROUP, LLC holds 17.11K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $8.95M, representing 0.84% of its reported portfolio and ranking #38.

Has LEUTHOLD GROUP, LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), LEUTHOLD GROUP, LLC increased its position in VRTX. The position peaked in Q3 2026 at 17.11K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.